Research · Sep 3, 2026
[KDP] Keurig Dr Pepper Thesis 2026: Bloom Nutrition Integration + Dr Pepper Category Strength + Selective Pricing Discipline Anchor Mid-Single-Digit Growth
Keurig Dr Pepper FY2025 revenue ~$15.5-16B (+3-5%) with adj. EPS ~$2.00-2.20 reflecting continued Dr Pepper category strength + selective pricing discipline + Bloom Nutrition acquisition contribution + International expansion partially offset by K-Cup single-serve coffee volume softness. Large US beverage company formed from $18.7B Keurig Green Mountain + Dr Pepper Snapple merger announced January 2018 (closed July 2018); JAB Holding Company controlling shareholder. 4 segments: US Refreshment Beverages ~$10B (~62%), US Coffee ~$4B (~25%), International ~$1.5B (~9%), Latin America ~$0.7B (~4%). CEO Tim Cofer since November 2024 (succeeded Bob Gamgort who became Executive Chair; Cofer ex-Mondelez International CEO 2023-2024 + ex-Kraft Foods). Bloom Nutrition $250M acquisition closed August 2024 added energy drink + selected wellness beverage brand into category overlap with Monster + Celsius. Dr Pepper US CSD share ~24-25% (gained selectively from Coca-Cola + Pepsi over multi-decade from ~5-6% in 1970s). Keurig single-serve coffee FY2024-2025 K-Cup volume softness -3 to -7% YoY (consumer trend toward cold brew + selected drip + selected affordability concerns). Capital return: dividend $0.92-0.96/share + buybacks $1-2B; net debt $13-14B; Baa1/BBB+ investment grade. FY2026 thesis: Bloom integration + Dr Pepper category strength + selective pricing + K-Cup stabilization. Risks: K-Cup softness extends, Dr Pepper category competition, commodity inflation.